Martin S. Tallman, MD, Begins Term as 2021 ASH President
(WASHINGTON, Jan. 7, 2021) — Martin S. Tallman, MD, a highly regarded leukemia expert, will serve as president of the American Society of Hematology (ASH) for a year-long term through December 2021.
Dr. Tallman is a Professor of Medicine at Weill Cornell Medical College and the Chief of the Leukemia Service at Memorial Sloan Kettering Cancer Center in New York City, where he holds the Cassidy Family Faculty Chair. Dr. Tallman’s research interests include clinical investigation in acute myeloid leukemia, acute lymphocytic leukemia, acute promyelocytic leukemia, and hairy cell leukemia.
“The most important issue facing hematology today is the remarkably rapid pace of progress in the discovery, dissemination, and integration of new knowledge,” said Dr. Tallman. “As ASH president, I look forward to facilitating connection and conversation among ASH members of all backgrounds and experience levels to improve care for those living with blood disorders. This is an especially vital mission now, when the COVID-19 pandemic shows what the hematology community can achieve when we come together and leverage our unique experiences, whether in the laboratory or the clinic, to ensure optimal care for our patients around the world. Through my past leadership activities at ASH, I have a wealth of knowledge about virtually all aspects of the Society that will enable me to advance our mission to promote research, clinical care, education, training, and advocacy in hematology in this important moment.”
Dr. Tallman has been a member of ASH for 21 years, and during that time he has served in various leadership roles representing the Society, most recently serving as an ASH Councillor and as ASH Vice President. He has completed a three-year term as the executive editor of Hematology, the Society’s education program book, and he helped establish the ASH Meeting on Hematologic Malignancies as a founding co-chair in 2015 and continued to serve as co-chair in 2016. He has also participated in several of ASH’s training and educational career development programs.
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, and Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.
Leah Enser, American Society of Hematology